Tryptamine Cowboy Chronicles on the Church of the Sacred Synthesis Podcast

In this first episode of the series Tryptamine Cowboy Chronicles, hosts Gabriel Hardy, Ian Benouis, and Benjamin Moore discuss the mission of the Church of the Sacred Synthesis, focusing on the healing potential of psychedelics, particularly Psilomethoxin. They explore the importance of community in accessing these substances, the challenges of legalizing psychedelics, and the innovative approaches they are taking to bring these medicines to the public. The conversation delves into the science behind Psilomethoxin, its unique properties compared to psilocybin, and the experiential differences reported by users. The episode concludes with a call to action for community involvement and transparency in the development of psychedelic therapies. Benjamin Moore (Ben) speaks first, describing his background working with psychedelics in retreats, especially for veterans. He explains that he believes these plant medicines are gifts that can help people, and he wants to make them more accessible. Ian Benouis discusses his experience as a Blackhawk helicopter pilot in Operation Just Cause and his subsequent PTSD. He shares his experience using Toad (5-MeO-DMT) for healing and how that led to his involvement with developing and providing access to psychedelic compounds, especially for veterans. He expresses his concern over veteran suicides. The conversation focuses on the potential of Psilomethoxin, a psychedelic compound that is reportedly effective in treating PTSD and other mental health conditions. They believe that it could be a safe and effective alternative to traditional pharmaceuticals and want to make it accessible to those in need. They discuss forming the Church of the Sacred Synthesis to protect the sacrament and PsiloCap as a company to protect the production process of Psilomethoxin. They aim to bring Psilomethoxin to market as an over-the-counter supplement through a pre-order model, bypassing the lengthy and expensive FDA approval process. They emphasize their commitment to transparency, community involvement, and providing education and resources about Psilomethoxin. The podcast delves into the differences between Psilomethoxin and other psychedelics like psilocybin, particularly regarding their effects on the nervous system and subjective experiences. They discuss the potential benefits of Psilomethoxin for treating PTSD, its potential for microdosing, and the importance of further research and data collection. They speak about the VA having a patent on Psilomethoxin for treating PTSD. The podcast ends with a call to action, encouraging listeners to learn more about Psilomethoxin, share the information, and support the mission of making this potentially life-changing medicine accessible to all. https://patents.google.com/patent/WO202402... VA Patent on Psilomethoxin for treating PTSD.